| RS1594910045 |
ZFYVE26
|
Health Risk |
Pathogenic |
Spastic paraplegia, Spastic paraplegia |
| RS1594910243 |
VIPAS39
|
Health Risk |
Likely pathogenic |
Arthrogryposis, renal dysfunction |
| RS1594912625 |
ZFYVE26
|
Health Risk |
Pathogenic |
Hereditary spastic paraplegia 15, Spastic paraplegia |
| RS1594913346 |
ZFYVE26
|
Health Risk |
Pathogenic |
Spastic paraplegia, Spastic paraplegia |
| RS1594915468 |
KIF5A
|
Health Risk |
Likely pathogenic |
Spastic paraplegia, Hereditary spastic paraplegia 10 |
| RS1594925773 |
KIF5A
|
Health Risk |
Pathogenic |
Spastic paraplegia, Spastic paraplegia |
| RS1594929571 |
VIPAS39
|
Health Risk |
Pathogenic |
Arthrogryposis, renal dysfunction |
| RS1594930532 |
ZFYVE26
|
Health Risk |
Pathogenic |
Spastic paraplegia, Spastic paraplegia |
| RS1594937657 |
ZFYVE26
|
Health Risk |
Likely pathogenic |
— |
| RS1594938339 |
ZFYVE26
|
Health Risk |
Pathogenic |
Spastic paraplegia, Spastic paraplegia |
| RS1594944871 |
SLC7A7
|
Health Risk |
Pathogenic |
Lysinuric protein intolerance, Lysinuric protein intolerance |
| RS1594952007 |
OTX2
|
Health Risk |
Pathogenic |
Syndromic microphthalmia type 5, Syndromic microphthalmia type 5 |
| RS1594952111 |
OTX2
|
Health Risk |
Pathogenic |
Syndromic microphthalmia type 5, Syndromic microphthalmia type 5 |
| RS1594952158 |
OTX2
|
Health Risk |
Likely pathogenic |
Anophthalmia-microphthalmia syndrome, Anophthalmia-microphthalmia syndrome |
| RS1594961338 |
PCCA
|
Health Risk |
Pathogenic |
Propionic acidemia, Propionic acidemia |
| RS1594961620 |
PCCA
|
Health Risk |
Likely pathogenic |
Propionic acidemia, Propionic acidemia |
| RS1594966387 |
ARID4A
|
Health Risk |
Likely pathogenic |
Multiple myeloma, Multiple myeloma |
| RS1594970015 |
GCH1
|
Health Risk |
Conflicting classifications of pathogenicity |
GTP cyclohydrolase I deficiency, Dystonia 5 |
| RS1594971274 |
GCH1
|
Health Risk |
Conflicting classifications of pathogenicity |
GTP cyclohydrolase I deficiency, Dystonia 5 |
| RS1594982548 |
SOS2
|
Health Risk |
Pathogenic |
Noonan syndrome, Noonan syndrome 9 |
| RS1594982939 |
GCH1
|
Health Risk |
Pathogenic |
GTP cyclohydrolase I deficiency, Dystonia 5 |
| RS1594986869 |
SPTLC2
|
Health Risk |
Pathogenic/Likely pathogenic |
Charcot-Marie-Tooth disease, Neuropathy |
| RS1594987281 |
PABPN1
|
Health Risk |
Pathogenic/Likely pathogenic |
Oculopharyngeal muscular dystrophy, Oculopharyngeal muscular dystrophy |
| RS1594989087 |
GCH1
|
Health Risk |
Likely pathogenic |
GTP cyclohydrolase I deficiency, Dystonia 5 |
| RS1594992191 |
PCCA
|
Health Risk |
Pathogenic/Likely pathogenic |
Propionic acidemia, Propionic acidemia |
| RS1594996301 |
SRP54
|
Health Risk |
Likely pathogenic |
Neutropenia, severe congenital |
| RS1594998354 |
PSEN1
|
Health Risk |
Likely pathogenic |
Alzheimer disease 3, Alzheimer disease 3 |
| RS1595001710 |
SOS2
|
Health Risk |
Pathogenic |
Noonan syndrome, Noonan syndrome 9 |
| RS1595004126 |
SRP54
|
Health Risk |
Pathogenic |
Neutropenia, severe congenital |
| RS1595004676 |
SRP54
|
Health Risk |
Pathogenic |
Neutropenia, severe congenital |
| RS1595009158 |
TTLL5
|
Health Risk |
Pathogenic |
Retinitis pigmentosa, Retinitis pigmentosa |
| RS1595009164 |
EIF2B2
|
Health Risk |
Likely pathogenic |
Vanishing white matter disease, Vanishing white matter disease |
| RS1595031209 |
GCH1
|
Health Risk |
Likely pathogenic |
GTP cyclohydrolase I deficiency, Dystonia 5 |
| RS1595031221 |
GCH1
|
Health Risk |
Pathogenic/Likely pathogenic |
GTP cyclohydrolase I deficiency, Dystonia 5 |
| RS1595031524 |
GCH1
|
Health Risk |
Pathogenic |
GTP cyclohydrolase I deficiency, Dystonia 5 |
| RS1595031674 |
GCH1
|
Health Risk |
Pathogenic |
GTP cyclohydrolase I deficiency, Dystonia 5 |
| RS1595031768 |
GCH1
|
Health Risk |
Pathogenic |
GTP cyclohydrolase I deficiency, GTP cyclohydrolase I deficiency |
| RS1595033018 |
PCCA
|
Health Risk |
Pathogenic |
Propionic acidemia, Propionic acidemia |
| RS1595035030 |
PSEN1
|
Health Risk |
Pathogenic |
Acne inversa, familial |
| RS1595050325 |
KIAA0586
|
Health Risk |
Pathogenic/Likely pathogenic |
Joubert syndrome 23, Joubert syndrome 23 |
| RS1595070689 |
MYH7
|
Health Risk |
Pathogenic/Likely pathogenic |
Hypertrophic cardiomyopathy, Myosin storage myopathy |
| RS1595070747 |
MYH7
|
Health Risk |
Pathogenic |
Hypertrophic cardiomyopathy, Hypertrophic cardiomyopathy |
| RS1595080617 |
F7
|
Health Risk |
Likely pathogenic |
Factor VII deficiency, Factor VII deficiency |
| RS1595080725 |
F7
|
Health Risk |
Likely pathogenic |
Abnormal bleeding, Abnormality of coagulation |
| RS1595080787 |
BCL11B
|
Health Risk |
Pathogenic |
— |
| RS1595081779 |
MYH7
|
Health Risk |
Conflicting classifications of pathogenicity |
Hypertrophic cardiomyopathy, Hypertrophic cardiomyopathy |
| RS1595084560 |
MYH7
|
Health Risk |
Likely pathogenic |
Hypertrophic cardiomyopathy, Cardiovascular phenotype |
| RS1595084583 |
MYH7
|
Health Risk |
Pathogenic |
Dilated cardiomyopathy 1S, Dilated cardiomyopathy 1S |
| RS1595085409 |
MYH7
|
Health Risk |
Conflicting classifications of pathogenicity |
Hypertrophic cardiomyopathy, Cardiovascular phenotype |
| RS1595085511 |
RALGAPA1
|
Health Risk |
Pathogenic |
Feeding difficulties, Neurodevelopmental disorder with hypotonia |
| RS1595086845 |
MYH7
|
Health Risk |
Conflicting classifications of pathogenicity |
Hypertrophic cardiomyopathy, Dilated cardiomyopathy 1S |
| RS1595089520 |
MYH7
|
Health Risk |
Conflicting classifications of pathogenicity |
Cardiovascular phenotype, Cardiovascular phenotype |
| RS1595091114 |
MYH7
|
Health Risk |
Conflicting classifications of pathogenicity |
Hypertrophic cardiomyopathy, Cardiomyopathy |
| RS1595098100 |
F10
|
Health Risk |
Likely pathogenic |
Abnormal bleeding, Abnormal bleeding |
| RS1595099527 |
F10
|
Health Risk |
Likely pathogenic |
Hereditary factor X deficiency disease, Hereditary factor X deficiency disease |
| RS1595099645 |
F10
|
Health Risk |
Likely pathogenic |
Hereditary factor X deficiency disease, Hereditary factor X deficiency disease |
| RS1595099844 |
F10
|
Health Risk |
Likely pathogenic |
Hereditary factor X deficiency disease, Hereditary factor X deficiency disease |
| RS1595102640 |
CALM1
|
Health Risk |
Pathogenic |
Catecholaminergic polymorphic ventricular tachycardia 4, Long QT syndrome 14 |
| RS1595108790 |
CDK4
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary cancer-predisposing syndrome, Familial melanoma |
| RS1595110484 |
CDK4
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary cancer-predisposing syndrome, Familial melanoma |
| RS1595110689 |
CDK4
|
Health Risk |
Conflicting classifications of pathogenicity |
Familial melanoma, Hereditary cancer-predisposing syndrome |
| RS1595110740 |
CDK4
|
Health Risk |
Conflicting classifications of pathogenicity |
Familial melanoma, Hereditary cancer-predisposing syndrome |
| RS1595112176 |
TECPR2
|
Health Risk |
Likely pathogenic |
— |
| RS1595123894 |
TECPR2
|
Health Risk |
Pathogenic/Likely pathogenic |
Hereditary spastic paraplegia 49, Hereditary spastic paraplegia 49 |
| RS1595127294 |
CDC42BPB
|
Health Risk |
Likely pathogenic |
CDC42BPB-related neurodevelopmental syndrome, Chilton-Okur-Chung neurodevelopmental syndrome |
| RS1595130972 |
MAX
|
Health Risk |
Likely pathogenic |
— |
| RS1595137877 |
TSFM
|
Health Risk |
Pathogenic/Likely pathogenic |
Fatal mitochondrial disease due to combined oxidative phosphorylation defect type 3, Fatal mitochondrial disease due to combined oxidative phosphorylation defect type 3 |
| RS1595158200 |
LOC130056226;SPATA7
|
Health Risk |
Pathogenic |
— |
| RS1595163730 |
INF2
|
Health Risk |
Likely pathogenic |
Focal segmental glomerulosclerosis 5, Focal segmental glomerulosclerosis 5 |
| RS1595163736 |
INF2
|
Health Risk |
Pathogenic |
Charcot-Marie-Tooth disease, Focal segmental glomerulosclerosis 5 |
| RS1595163820 |
INF2
|
Health Risk |
Likely pathogenic |
Charcot-Marie-Tooth disease, Charcot-Marie-Tooth disease dominant intermediate E |
| RS1595163851 |
INF2
|
Health Risk |
Likely pathogenic |
Charcot-Marie-Tooth disease, Focal segmental glomerulosclerosis 5 |
| RS1595164081 |
INF2
|
Health Risk |
Pathogenic |
Charcot-Marie-Tooth disease, Focal segmental glomerulosclerosis 5 |
| RS1595164091 |
INF2
|
Health Risk |
Pathogenic |
Charcot-Marie-Tooth disease, Focal segmental glomerulosclerosis 5 |
| RS1595166085 |
INF2
|
Health Risk |
Pathogenic/Likely pathogenic |
Focal segmental glomerulosclerosis 5, INF2-related disorder |
| RS1595166895 |
MAX
|
Health Risk |
Pathogenic |
Hereditary pheochromocytoma and paraganglioma, Hereditary pheochromocytoma and paraganglioma |
| RS1595168879 |
TTLL5
|
Health Risk |
Pathogenic/Likely pathogenic |
— |
| RS1595179250 |
TSHR
|
Health Risk |
Pathogenic/Likely pathogenic |
— |
| RS1595184407 |
TPP2
|
Health Risk |
Pathogenic |
Evans syndrome, immunodeficiency |
| RS1595188566 |
TPP2
|
Health Risk |
Pathogenic |
Evans syndrome, immunodeficiency |
| RS1595190129 |
GALC
|
Health Risk |
Likely pathogenic |
Galactosylceramide beta-galactosidase deficiency, Galactosylceramide beta-galactosidase deficiency |
| RS1595202534 |
PCCA
|
Health Risk |
Likely pathogenic |
Propionic acidemia, Propionic acidemia |
| RS1595202607 |
PCCA
|
Health Risk |
Likely pathogenic |
Propionic acidemia, Propionic acidemia |
| RS1595204045 |
PCCA
|
Health Risk |
Likely pathogenic |
Propionic acidemia, Propionic acidemia |
| RS1595208914 |
CDC42BPB
|
Health Risk |
Likely pathogenic |
CDC42BPB-related neurodevelopmental syndrome, CDC42BPB-related neurodevelopmental syndrome |
| RS1595214071 |
BCL11B
|
Health Risk |
Pathogenic |
Intellectual developmental disorder with speech delay, dysmorphic facies |
| RS1595214545 |
BCL11B
|
Health Risk |
Pathogenic |
— |
| RS1595214864 |
BCL11B
|
Health Risk |
Pathogenic |
— |
| RS1595215209 |
GALC
|
Health Risk |
Pathogenic |
Galactosylceramide beta-galactosidase deficiency, Galactosylceramide beta-galactosidase deficiency |
| RS1595215462 |
BCL11B
|
Health Risk |
Pathogenic |
Intellectual developmental disorder with speech delay, dysmorphic facies |
| RS1595231072 |
ISCA2
|
Health Risk |
Conflicting classifications of pathogenicity |
Multiple mitochondrial dysfunctions syndrome 4, Multiple mitochondrial dysfunctions syndrome 4 |
| RS1595236063 |
PCCA
|
Health Risk |
Likely pathogenic |
Propionic acidemia, Propionic acidemia |
| RS1595236714 |
GALC
|
Health Risk |
Likely pathogenic |
Galactosylceramide beta-galactosidase deficiency, Galactosylceramide beta-galactosidase deficiency |
| RS1595241291 |
GPHN
|
Health Risk |
Pathogenic |
Sulfite oxidase deficiency due to molybdenum cofactor deficiency type C, Sulfite oxidase deficiency due to molybdenum cofactor deficiency type C |
| RS1595246385 |
GALC
|
Health Risk |
Likely pathogenic |
Galactosylceramide beta-galactosidase deficiency, Galactosylceramide beta-galactosidase deficiency |
| RS1595251483 |
AKT1
|
Health Risk |
Pathogenic |
Proteus syndrome, Proteus syndrome |
| RS1595270842 |
SPATA7
|
Health Risk |
Conflicting classifications of pathogenicity |
Retinal dystrophy, Leber congenital amaurosis 3 |
| RS1595286986 |
FBLN5
|
Health Risk |
Pathogenic |
Macular degeneration, age-related |
| RS1595298328 |
MKRN3
|
Health Risk |
Likely pathogenic |
— |
| RS1595309671 |
YY1
|
Health Risk |
Pathogenic |
— |